These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Ergospirometry in sarcoidosis patients]. Schwaiblmair M; Hettich R; Fruhmann G Z Kardiol; 1994; 83 Suppl 3():163-8. PubMed ID: 7941666 [TBL] [Abstract][Full Text] [Related]
3. [Change of pulmonary diffusing capacity, membrane diffusing capacity and pulmonary capillary blood volume in patients with COPD and connective tissue disease at rest and post-exercise]. Chi L; Liu Y; Piao Z Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jun; 21(6):344-7. PubMed ID: 11326890 [TBL] [Abstract][Full Text] [Related]
5. [Respiratory mechanics in patients with stage III pulmonary sarcoidosis and idiopathic fibrosing alveolitis: similarities and differences]. Bogorodskaia EM; Evfim'evskiĭ VO; Borisov SE Probl Tuberk Bolezn Legk; 2006; (4):41-5. PubMed ID: 16813060 [TBL] [Abstract][Full Text] [Related]
6. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases. Majumdar S; Sen S; Mandal SK J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952 [TBL] [Abstract][Full Text] [Related]
7. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study. Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP; Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967 [TBL] [Abstract][Full Text] [Related]
8. [Comparison in patients with chronic bronchitis of the data offered by the output-volume loop and the transfer capacity of CO]. Feliciano JM; Alinescu R; Poirier R; Artinian H; Laval P Poumon Coeur; 1975; 31(5):297-301. PubMed ID: 1226349 [TBL] [Abstract][Full Text] [Related]
9. Effects of steroid therapy on pulmonary involvement in sarcoidosis. Scano G; Monechi GC; Gigliotti F; Stendardi L; Esposito-Iacenna V; Tarducci G; Schiffini P Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):468-75. PubMed ID: 6629552 [TBL] [Abstract][Full Text] [Related]
10. [Comparative functional study of 25 patients with intrathoracic sarcoidosis (author's transl)]. Pacheco Galván A; Ruiz de Andrés S; Estada JA; Renart MA; García Carmona T Med Clin (Barc); 1979 May; 72(10):405-9. PubMed ID: 470487 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary complications after lung resection in the absence of chronic obstructive pulmonary disease: the predictive role of diffusing capacity. Ferguson MK; Gaissert HA; Grab JD; Sheng S J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1297-302. PubMed ID: 19783010 [TBL] [Abstract][Full Text] [Related]
12. [Disorders of the ventilatory mechanics in patients with respiratory sarcoidosis]. Evfim'evskiĭ VP; Romanov VV Probl Tuberk; 1989; (9):34-7. PubMed ID: 2587547 [TBL] [Abstract][Full Text] [Related]
13. Surgical therapy for chronic obstructive pulmonary disease. Martinez FJ; Chang A Semin Respir Crit Care Med; 2005 Apr; 26(2):167-91. PubMed ID: 16088435 [TBL] [Abstract][Full Text] [Related]
14. [Ventilatory and gas exchange functions of the lungs in occupational and other pulmonary diseases]. Liubchenko PN; Massarygin VV; Terpigorev SA; Shirokova EB; Shumskaia OV Ter Arkh; 2007; 79(12):65-9. PubMed ID: 18220036 [TBL] [Abstract][Full Text] [Related]
15. Single-breath gas distribution in chronic obstructive lung disease. Isoproterenol effect on neon dilution volume and diffusing capacity. Daly WJ Arch Intern Med; 1971 Apr; 127(4):763-6. PubMed ID: 4929240 [No Abstract] [Full Text] [Related]
16. [Effects of systemic glucocorticoid hormones on functional indices of the respiratory system in patients with chronic obstructive pulmonary disease during acute phase]. Komlev AD; Kuziaev AI; Kuzenkova VE; Laskin GM; Kolosova MV Ter Arkh; 2007; 79(3):21-5. PubMed ID: 17526190 [TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics, pulmonary function abnormalities and outcome of prednisolone treatment in 106 patients with sarcoidosis. Sharma SK; Mohan A; Guleria JS J Assoc Physicians India; 2001 Jul; 49():697-704. PubMed ID: 11573554 [TBL] [Abstract][Full Text] [Related]
18. Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease. Ferguson MK; Vigneswaran WT Ann Thorac Surg; 2008 Apr; 85(4):1158-64; discussion 1164-5. PubMed ID: 18355489 [TBL] [Abstract][Full Text] [Related]
19. Fractional carbon monoxide uptake and "diffusing capacity" in models of pulmonary maldistribution. Harris EA; Whitlock RM Bull Eur Physiopathol Respir; 1983; 19(5):427-32. PubMed ID: 6640162 [TBL] [Abstract][Full Text] [Related]